Nutritionists

 Annie presented a lecture though MyCatholicDoctor, which deciphers fact from fiction in the “health” world. Not only will you come away with knowledge and understanding of the whys and why-nots of nutrition, but learn how to set yourself up for success in creating simple and sustainable change toward a 

healthier you! To enjoy Annie's lecture the image to the right or just click here.  

Personally, I don't recommend full dose GLP-1 agonists for weight loss because I don't think we have had enough time to demonstrate long-term safety of these drugs. However, GLP-1  agonists at lower doses have  been used to treat type 2 diabetes for over 20 years. The first GLP-1 was called exenatide (Byetta) and was approved by the FDA in April 2025. Since then,  many other GLP-1 agonists came on to the market. 

1. Tirzepatide
2. Semaglutide,
3. Liraglutide 

For my patients who are overweight and having problems achieving a pregnancy, I would recommend you consider making an appt with either your primary care doctor or with a provider at Lavender Sly Health to be evaluated to see if a GLP-1 agonist is right for you. If your provider agrees, my recommendations would be to try a very low dose of Tirzepatide such as 2.5 mg daily and titrate up to 4-4.5 mg as needed to achieve weight loss. In my experirence, this small dose (typically used for Diabetes) is successful in helping women who are overweight lose weight when combined with a good diet and daily exercise. These life-style changes are of the utmost importance, since oftentimes, this will allow the patients to wean off the GLP-1 agonist when their weight loss is achieved without gaining the weight back. 

The amazing benefit is, there appears to be lot of research being published showing that when GLP-1 agonists are taken (via an injectable) women are ovulating more! What an awesome, exciting unexpected side effec!